These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 20833794

  • 21. Antagonism of protease-activated receptor 2 protects against experimental colitis.
    Lohman RJ, Cotterell AJ, Suen J, Liu L, Do AT, Vesey DA, Fairlie DP.
    J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
    [Abstract] [Full Text] [Related]

  • 22. Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice.
    Kim HB, Kim M, Park YS, Park I, Kim T, Yang SY, Cho CJ, Hwang D, Jung JH, Markowitz SD, Hwang SW, Yang SK, Lim DS, Myung SJ.
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, Mizushima T.
    Eur J Pharmacol; 2009 Jan 28; 603(1-3):120-32. PubMed ID: 19101538
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M, Sunil Kumar KB, Palanichamy S, Rampal A.
    Int Immunopharmacol; 2016 Nov 28; 40():443-451. PubMed ID: 27716592
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.
    Peng XD, Wu XH, Chen LJ, Wang ZL, Hu XH, Song LF, He CM, Luo YF, Chen ZZ, Jin K, Lin HG, Li XL, Wang YS, Wei YQ.
    J Pharmacol Exp Ther; 2010 Jan 28; 332(1):46-56. PubMed ID: 19828878
    [Abstract] [Full Text] [Related]

  • 33. Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling.
    Martínez-Augustin O, López-Posadas R, González R, Suárez MD, Zarzuelo A, Sánchez de Medina F.
    Pharmacogenet Genomics; 2009 May 28; 19(5):363-72. PubMed ID: 19365232
    [Abstract] [Full Text] [Related]

  • 34. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM.
    Gastroenterology; 2009 Jun 28; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [Abstract] [Full Text] [Related]

  • 35. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
    Schmidt N, Gonzalez E, Visekruna A, Kühl AA, Loddenkemper C, Mollenkopf H, Kaufmann SH, Steinhoff U, Joeris T.
    Gut; 2010 Jul 28; 59(7):896-906. PubMed ID: 20581238
    [Abstract] [Full Text] [Related]

  • 36. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
    Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J.
    J Clin Immunol; 2007 May 28; 27(3):275-83. PubMed ID: 17510806
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S, Rapoport M, Grodzovski I, Sabag O, Lichtenstein M, Eavri R, Lorberboum-Galski H.
    Gut; 2009 Jun 28; 58(6):790-8. PubMed ID: 18978179
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An arachidonic acid-enriched diet does not result in more colonic inflammation as compared with fish oil- or oleic acid-enriched diets in mice with experimental colitis.
    Ramakers JD, Mensink RP, Verstege MI, te Velde AA, Plat J.
    Br J Nutr; 2008 Aug 28; 100(2):347-54. PubMed ID: 18205994
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.